In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for February 2022
The National Cancer Institute approved the following clinical research study last month.
Trending Stories
- Thermo Fisher introduces assays for MRD detection in myeloid malignancies
- Chernobyl: a 35 year follow up on long-term health effects
- Betty Ford and the press conference that changed oncology
- White House to appoint Monica Bertagnolli as 16th NCI director
- What are you reading in 2022?
- Patient navigation improves outcomes and addresses health equity across the cancer continuum